Sonoma Pharmaceuticals Inc (SNOA)

Apr 22, 2025, 4:01 PM EDT - 6 weeks ago

Sonoma Pharmaceuticals Announces Registration of Acne Products in the United Kingdom and Launch of the Products in Leading U.K. Pharmacy Chain

Mar 10, 2025, 4:01 PM EDT - 3 months ago

Sonoma Pharmaceuticals Secures Extensive U.K. Regulatory Clearances of Key Wound Care and Dermatology Products by the Medicines & Healthcare Products Regulatory Agency (MHRA)

Feb 25, 2025, 4:01 PM EST - 3 months ago

Sonoma Pharmaceuticals to Exhibit at 2025 American Academy of Dermatology Annual Meeting in Orlando

Feb 5, 2025, 4:05 PM EST - 4 months ago

Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2025 Financial Results

Dec 5, 2024, 8:30 AM EST - 6 months ago

Sonoma Pharmaceuticals Successfully Transitions First Products to New EU MDR Requirements for Class IIb Medical Devices

Nov 21, 2024, 4:06 PM EST - 7 months ago

Sonoma Pharmaceuticals Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in the United States

Nov 11, 2024, 4:20 PM EST - 7 months ago

Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn(R)-based Wound Care Hydrogel

Nov 7, 2024, 8:45 AM EST - 7 months ago

Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2025 Financial Results

Oct 31, 2024, 4:01 PM EDT - 7 months ago

Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Düsseldorf

Oct 22, 2024, 8:35 AM EDT - 8 months ago

Sonoma Pharmaceuticals Announces Expanded Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in Canada

Oct 21, 2024, 4:01 PM EDT - 8 months ago

Sonoma Pharmaceuticals to Present at Danisavage Financial Strategies, and LD Micro Main Event XVII Investor Conferences

Sep 19, 2024, 8:30 AM EDT - 9 months ago

Sonoma Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule

Sep 17, 2024, 8:30 AM EDT - 9 months ago

Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance with Expanded Indications for Over-the-Counter Microcyn(R)-Based Solution

Sep 11, 2024, 8:30 AM EDT - 9 months ago

Sonoma Pharmaceuticals and EMC Pharma Announce Collaboration to Co-market an Expanded Eye Care Product Line

Aug 28, 2024, 6:10 AM EDT - 10 months ago

Sonoma Pharmaceuticals Announces 1-for-20 Reverse Split of Outstanding Common Stock

Aug 26, 2024, 8:30 AM EDT - 10 months ago

Sonoma Pharmaceuticals and MicroSafe Group Announce that Nanocyn(R) Disinfectant & Sanitizer has been Approved by the Australian TGA as Effective Against Candida auris and C-Diff

Aug 21, 2024, 8:45 AM EDT - 10 months ago

Sonoma Pharmaceuticals Announces Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in the United States

Aug 8, 2024, 4:10 PM EDT - 10 months ago

Sonoma Pharmaceuticals Reports First Fiscal Quarter 2025 Financial Results

Jul 9, 2024, 7:30 AM EDT - 11 months ago

Sonoma Pharmaceuticals Celebrates 20 Years of Selling Wound Care Products in Europe and Announces New Distributor in Ukraine

Jun 17, 2024, 5:00 PM EDT - 1 year ago

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2024 Financial Results

May 9, 2024, 7:30 AM EDT - 1 year ago

Sonoma Pharmaceuticals Announces MicrocynAH for Animal Health Now Available Through Menards Home Improvement Stores

Apr 9, 2024, 7:30 AM EDT - 1 year ago

Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United States

Apr 4, 2024, 7:30 AM EDT - 1 year ago

Sonoma Pharmaceuticals Reports Recent Publication from Australia Highlighting Potential for Microdox in Managing Urinary Tract Infections

Mar 28, 2024, 4:01 PM EDT - 1 year ago

Sonoma Pharmaceuticals to Present at Trickle Research and LD Micro Investor Conferences

Mar 27, 2024, 7:30 AM EDT - 1 year ago

Sonoma Pharmaceuticals Highlights Safety Advantages of its Microcyn Products in Light of Growing Concerns of Benzene in Many Other Topicals

Feb 8, 2024, 4:10 PM EST - 1 year ago

Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2024 Financial Results

Jan 23, 2024, 7:30 AM EST - 1 year ago

Sonoma Pharmaceuticals Introduces Lumacyn Clarifying Mist, an All Natural, Over-the-Counter Skincare Product for Daily Use

Jan 9, 2024, 9:15 AM EST - 1 year ago

NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma's Extensive Distributor Network

NBY

Nov 13, 2023, 4:10 PM EST - 1 year ago

Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2024 Financial Results

Nov 3, 2023, 7:30 AM EDT - 1 year ago

Sonoma Pharmaceuticals Announces U.S. Launch of Next Generation Advanced Solution for Pulse Lavage Irrigation at the Symposium on Advanced Wound Care Fall Conference

Oct 26, 2023, 9:10 AM EDT - 1 year ago

Sonoma Pharmaceuticals, Inc. Announces Pricing of $1.7 Million Public Offering of Common Stock

Aug 15, 2023, 7:30 AM EDT - 1 year ago

National Eczema Association Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced

Aug 10, 2023, 4:15 PM EDT - 1 year ago

Sonoma Pharmaceuticals Reports First Fiscal Quarter 2024 Financial Results

Aug 3, 2023, 7:30 AM EDT - 2 years ago

Sonoma Pharmaceuticals Announces Appointment of Hye Jin Chung, M.D. to Scientific Advisory Board

Jun 22, 2023, 7:30 AM EDT - 2 years ago

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2023 Financial Results

Jun 9, 2023, 5:05 PM EDT - 2 years ago

Sonoma Pharmaceuticals Shares Soar 44% After Introducing New Product

Jun 8, 2023, 4:01 PM EDT - 2 years ago

Sonoma Pharmaceuticals Introduces Next Generation Solution for Pulse Lavage Irrigation in the European Union

Apr 11, 2023, 7:30 AM EDT - 2 years ago

Sonoma Pharmaceuticals Introduces Podiacyn, an All Natural, Over-the-Counter Podiatry Product for Daily Foot Care

Mar 28, 2023, 4:15 PM EDT - 2 years ago

Sonoma Pharmaceuticals to Exhibit at Upcoming CPHI North America Conference in Philadelphia

Mar 2, 2023, 7:30 AM EST - 2 years ago

Sonoma Pharmaceuticals and MicroSafe Group Announce New EPA Claims and Green Seal Certification for Nanocyn(R) Hospital-Grade Disinfectant

Feb 14, 2023, 4:30 PM EST - 2 years ago

Sonoma Pharmaceuticals Reports Third Quarter 2023 Financial Results

Jan 31, 2023, 7:30 AM EST - 2 years ago

Sonoma Pharmaceuticals Announces Partnership with Daewoong Pharmaceutical for Distribution of Primocyn Skin Care in South Korea

Jan 25, 2023, 7:30 AM EST - 2 years ago

Sonoma Pharmaceuticals and EMC Pharma Announce Department of Defense DAPA Registration for Microcyn(R) Rx Products

Jan 4, 2023, 7:30 AM EST - 2 years ago

Sonoma Pharmaceuticals Launches Two New Products Expanding Its Line of Office Dispense Products Exclusively for Dermatologists and Medical Spas

Nov 14, 2022, 4:15 PM EST - 2 years ago

Sonoma Pharmaceuticals Reports Second Quarter 2023 Financial Results

Oct 27, 2022, 4:01 PM EDT - 2 years ago

Sonoma Pharmaceuticals Launches Two New Dermatological Products for Over-The-Counter Use in the United States

Oct 6, 2022, 4:15 PM EDT - 2 years ago

Sonoma Pharmaceuticals to Exhibit at Upcoming CPHI Conference in Frankfurt, Germany

Aug 11, 2022, 4:30 PM EDT - 3 years ago

Sonoma Pharmaceuticals Reports First Quarter 2023 Financial Results

Aug 2, 2022, 4:30 PM EDT - 3 years ago

Sonoma Pharmaceuticals Launches MicrocynVS(R) Line of Products Exclusively for Veterinarian Use and Announces Partnership with DV Medical Supply

Jul 13, 2022, 4:45 PM EDT - 3 years ago

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2022 Financial Results